EarningsORIONPHARM
ORIONPHARM Earnings Update
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 30 January 2025. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Q2 Un-audited): Consolidated EPS was Tk. (0.44) for October-December 2024 as against Tk. 0.47 for October-December 2023; Consolidated EPS was Tk. (0.20) for July-December 2024 as against Tk. 1.23 for July-December 2023. Consolidated NOCFPS was Tk. 4.26 for July-December 2024 as against Tk. 2.68 for July-December 2023. Consolidated NAV per share including revaluation surplus was Tk. 89.82 as on December 31, 2024 and Tk. 92.05 as on June 30, 2024. (cont.)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 679af724658c52fc96a26393
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.